uric acid has been researched along with Angina Pectoris, Stable in 2 studies
Uric Acid: An oxidation product, via XANTHINE OXIDASE, of oxypurines such as XANTHINE and HYPOXANTHINE. It is the final oxidation product of purine catabolism in humans and primates, whereas in most other mammals URATE OXIDASE further oxidizes it to ALLANTOIN.
uric acid : An oxopurine that is the final oxidation product of purine metabolism.
6-hydroxy-1H-purine-2,8(7H,9H)-dione : A tautomer of uric acid having oxo groups at C-2 and C-8 and a hydroxy group at C-6.
7,9-dihydro-1H-purine-2,6,8(3H)-trione : An oxopurine in which the purine ring is substituted by oxo groups at positions 2, 6, and 8.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Serum uric acid (SUA) level was shown in various studies to be related to the presence of coronary artery disease and subsequent cardiovascular events." | 3.91 | Association of serum uric acid levels with SYNTAX score II and long term mortality in the patients with stable angina pectoris who undergo percutaneous coronary interventions due to multivessel and/or unprotected left main disease. ( Atalay, E; Burak, C; Çağdaş, M; Çağdaş, ÖS; Gürsoy, MO; Karabağ, Y; Karakoyun, S; Rencuzogullari, I; Tanboğa, HI; Yesin, M, 2019) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Karabağ, Y | 1 |
| Rencuzogullari, I | 1 |
| Çağdaş, M | 1 |
| Karakoyun, S | 1 |
| Yesin, M | 1 |
| Atalay, E | 1 |
| Çağdaş, ÖS | 1 |
| Gürsoy, MO | 1 |
| Burak, C | 1 |
| Tanboğa, HI | 1 |
| Iwata, A | 1 |
| Miura, S | 1 |
| Tanaka, T | 1 |
| Ike, A | 1 |
| Sugihara, M | 1 |
| Nishikawa, H | 1 |
| Kawamura, A | 1 |
| Saku, K | 1 |
2 other studies available for uric acid and Angina Pectoris, Stable
| Article | Year |
|---|---|
Association of serum uric acid levels with SYNTAX score II and long term mortality in the patients with stable angina pectoris who undergo percutaneous coronary interventions due to multivessel and/or unprotected left main disease.
Topics: Aged; Angina, Stable; Biomarkers; Coronary Angiography; Coronary Artery Disease; Female; Humans; Hyp | 2019 |
Plasma pentraxin-3 levels are associated with coronary plaque vulnerability and are decreased by statin.
Topics: Aged; Angina, Stable; Atorvastatin; Biomarkers; C-Reactive Protein; Case-Control Studies; Chi-Square | 2012 |